Dr. Gaston De Serres is an epidemiologist practitioner at the l’Institut national de santé publique du Québec and a regular researcher in the Infectious and Immune Disease Axis at the CHU de Québec-Laval University. He is a full professor in epidemiology in the Department of social and preventive medicine at Laval University where he has been teaching since 1997. He is chief physician of the scientific immunization group (SIG) of the Institut national de santé publique du Québec and an active member of the Comité sur l’immunisation du Québec (CIQ).

Dr. De Serre works on the control and prevention of infectious diseases, with a focus on diseases that are avoidable through vaccination and on respiratory diseases. His research work is on the epidemiology of diseases that are preventable through vaccination and the efficacy of vaccinations used in routine programs, and in particular, on the efficacy of the influenza vaccine.

2400, avenue d'Estimauville, 3e étage
Québec, Québec
Canada G1E 7G9
320 entries « 1 of 32 »

Skowronski DM, De Serres G

Evidence in a Cluster Randomized Controlled Trial of Increased 2009 Pandemic Risk Associated With 2008-2009 Seasonal Influenza Vaccine Receipt.

Journal Article

Clin Infect Dis, 69 (12), pp. 2230-2231, 2019, ISSN: 1058-4838.

| Links:

Kiely M, Boulianne N, Talbot D, Ouakki M, Guay M, Landry M, Sauvageau C, De Serres G

Children vaccination coverage surveys: Impact of multiple sources of information and multiple contact attempts.

Journal Article

Vaccine, 2019, ISSN: 0264-410X.

Abstract | Links:

Brousseau N, Skowronski DM, Bellemare D, Amini R, Joffres Y, Clarke Q, Quach C, Rallu F, Hoang L, De Serres G

Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada.

Journal Article

Vaccine, 2019, ISSN: 0264-410X.

Abstract | Links:

Skowronski DM, Sabaiduc S, Leir S, Rose C, Zou M, Murti M, Dickinson JA, Olsha R, Gubbay JB, Croxen MA, Charest H, Bastien N, Li Y, Jassem A, Krajden M, De Serres G

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).

Journal Article

Euro Surveill, 24 (46), 2019, ISSN: 1025-496X.

Abstract | Links:

Sauvageau C, Panicker G, Unger ER, De Serres G, Schiller J, Ouakki M, Gilca V

Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials.

Journal Article

Hum Vaccin Immunother, pp. 1-5, 2019.

Abstract | Links:

Skowronski DM, De Serres G, Orenstein WA

Caution Required in the Use of Administrative Data and General Laboratory Submissions for Influenza Vaccine Effectiveness Estimation.

Journal Article

Clin Infect Dis, 69 (6), pp. 1084-1085, 2019, ISSN: 1058-4838.

| Links:

De Serres G, Billard MN, Gariepy MC, Roy MC, Boucher FD, Gagne H, Belley S, Toth E, Landry M, Skowronski DM

Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal.

Journal Article

Vaccine, 37 (35), pp. 4996-5002, 2019, ISSN: 0264-410X.

Abstract | Links:

Amini R, Gilca R, Boucher FD, Charest H, De Serres G

Respiratory syncytial virus contributes to more severe respiratory morbidity than influenza in children < 2 years during seasonal influenza peaks.

Journal Article

Infection, 47 (4), pp. 595-601, 2019, ISSN: 0300-8126.

Abstract | Links:

Gilca V, Sauvageau C, De Serres G

A mixed vaccination schedule of HPV vaccine induces a 100% seropositivity to all 9 HPV types included in 9vHPV vaccine.

Journal Article

Vaccine, 37 (32), pp. 4422-4423, 2019, ISSN: 0264-410X.

| Links:

Deceuninck G, Lefebvre B, Tsang R, Betala-Belinga JF, De Serres G, De Wals P

Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch.

Journal Article

Vaccine, 37 (31), pp. 4243-4245, 2019, ISSN: 0264-410X.

Abstract | Links:

320 entries « 1 of 32 »
Signaler des ajouts ou des modifications

Active projects

  • (CV04 QC03) CANVAS Network - Surveillance of adverse events following immunization among children and adults immunized with the influenza vaccine, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2017-06-01 to 2022-03-31
  • (SI03 QC03) Special Immunization Clinic Network (SIC) to investigate vaccine safety issues: Optimizing the clinical management of patients with contraindication to vaccination ..., Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2019-04-01 to 2022-03-31
  • Canadian Immunization Research Network, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2014-06-01 to 2021-12-31
  • Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
  • Interchangeabilité des vaccins VPH., Subvention, Ministère de la Santé et des Services sociaux, from 2011-03-29 to 2019-12-31

Recently finished projects

  • Enquête sur la couverture vaccinale des enfants québécois pour les vaccins administrés avant l'entrée scolaire 2017, Subvention, Institut national de santé publique du Québec, from 2016-09-09 to 2018-12-31
  • PHAC / CIHR Influenza Research Network, Subvention, Instituts de recherche en santé du Canada, from 2012-06-01 to 2019-03-31
Data provided by the Université Laval research projects registery